-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Decoction pieces of traditional Chinese medicine refer to traditional Chinese medicinal materials and their processed products that can be directly used for preparation or preparation under the guidance of traditional Chinese medicine theory
.
According to data, in 2018, the market size of traditional Chinese medicine decoction pieces has reached about 220 billion yuan, and the market is still growing steadily
.
However, it is worth noting that with the continuous expansion of the market, more and more specifications have been issued in recent years for the development of traditional Chinese medicine pieces
.
Recently, the Zhejiang Provincial Medical Insurance Bureau issued the "Notice on Further Doing a Good Job in the Implementation of the Implementation Opinions on Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" (hereinafter referred to as the "Notice"), addressing issues such as the range of price increases, coding and settlement of Chinese herbal medicines.
A more detailed answer is given
.
Among them, it is worth mentioning that in terms of the increase in the price of Chinese medicine pieces, the "Notice" also clarifies the space for the "two determinations" agencies to increase the price of Chinese medicine pieces
.
Specifically, the notice proposes that the price increase of designated public medical institutions shall not exceed 25% of the actual purchase price, and other designated medical institutions shall implement the two-determined agreement, and the medical insurance payment standard shall still be formulated according to the actual purchase price plus no more than 25%
.
In this regard, the industry believes that the traditional Chinese medicine pieces and prepared Chinese medicine preparations prepared by medical institutions shall be priced independently, and the sales markup rate shall be controlled within 25%, which means that the Chinese medicine pieces will have a larger price space, which will benefit the development of the Chinese medicine piece industry.
.
It is understood that this regulation is not a start-up in Zhejiang Province.
In the "Opinions on Further Rectifying the Price Order of the Drug and Medical Services Market" issued by the National Development and Reform Commission and other 8 departments earlier, it was clarified that the increase rate of traditional Chinese medicine pieces should be controlled at 25% Within, shall not exceed the markup rate sales
.
In addition, in the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" issued on December 30, 2019, it was also clarified that public medical institutions purchase traditional Chinese medicine pieces from formal channels and sell them in strict accordance with the actual purchase price
.
In the context of the normalization of centralized procurement across the country and the intensive monitoring of public hospitals, this regulation has made many traditional western medicine companies envious
.
The industry believes that, on the whole, this regulation will give medical institutions more buffer periods, which will help to fully explore the reform methods that meet the characteristics of traditional Chinese medicine services, and will benefit the future development of the traditional Chinese medicine industry.
.
However, it should be noted that under the tide of medical reform, the traditional Chinese medicine industry, including Chinese herbal decoction pieces, will surely embark on a more standardized road, and price reduction will also become an inevitable trend
.
Therefore, for related enterprises, if they want to obtain more development opportunities and enhance their competitiveness in the future, they still need to continue to innovate and upgrade to further improve the quality control level and quality of Chinese herbal decoction pieces.
On the premise of ensuring the safety of public medication , to promote its own high-quality development
.
It is understood that many TCM decoction pieces companies have already embarked on the road of modern production, and are promoting the high-quality and large-scale development of TCM decoction pieces by continuously strengthening the application of automated production lines
.
.
According to data, in 2018, the market size of traditional Chinese medicine decoction pieces has reached about 220 billion yuan, and the market is still growing steadily
.
However, it is worth noting that with the continuous expansion of the market, more and more specifications have been issued in recent years for the development of traditional Chinese medicine pieces
.
Recently, the Zhejiang Provincial Medical Insurance Bureau issued the "Notice on Further Doing a Good Job in the Implementation of the Implementation Opinions on Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" (hereinafter referred to as the "Notice"), addressing issues such as the range of price increases, coding and settlement of Chinese herbal medicines.
A more detailed answer is given
.
Among them, it is worth mentioning that in terms of the increase in the price of Chinese medicine pieces, the "Notice" also clarifies the space for the "two determinations" agencies to increase the price of Chinese medicine pieces
.
Specifically, the notice proposes that the price increase of designated public medical institutions shall not exceed 25% of the actual purchase price, and other designated medical institutions shall implement the two-determined agreement, and the medical insurance payment standard shall still be formulated according to the actual purchase price plus no more than 25%
.
In this regard, the industry believes that the traditional Chinese medicine pieces and prepared Chinese medicine preparations prepared by medical institutions shall be priced independently, and the sales markup rate shall be controlled within 25%, which means that the Chinese medicine pieces will have a larger price space, which will benefit the development of the Chinese medicine piece industry.
.
It is understood that this regulation is not a start-up in Zhejiang Province.
In the "Opinions on Further Rectifying the Price Order of the Drug and Medical Services Market" issued by the National Development and Reform Commission and other 8 departments earlier, it was clarified that the increase rate of traditional Chinese medicine pieces should be controlled at 25% Within, shall not exceed the markup rate sales
.
In addition, in the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" issued on December 30, 2019, it was also clarified that public medical institutions purchase traditional Chinese medicine pieces from formal channels and sell them in strict accordance with the actual purchase price
.
In the context of the normalization of centralized procurement across the country and the intensive monitoring of public hospitals, this regulation has made many traditional western medicine companies envious
.
The industry believes that, on the whole, this regulation will give medical institutions more buffer periods, which will help to fully explore the reform methods that meet the characteristics of traditional Chinese medicine services, and will benefit the future development of the traditional Chinese medicine industry.
.
However, it should be noted that under the tide of medical reform, the traditional Chinese medicine industry, including Chinese herbal decoction pieces, will surely embark on a more standardized road, and price reduction will also become an inevitable trend
.
Therefore, for related enterprises, if they want to obtain more development opportunities and enhance their competitiveness in the future, they still need to continue to innovate and upgrade to further improve the quality control level and quality of Chinese herbal decoction pieces.
On the premise of ensuring the safety of public medication , to promote its own high-quality development
.
It is understood that many TCM decoction pieces companies have already embarked on the road of modern production, and are promoting the high-quality and large-scale development of TCM decoction pieces by continuously strengthening the application of automated production lines
.
